Advertisement

Medical Oncology and Tumor Pharmacotherapy

, Volume 2, Issue 3, pp 189–193 | Cite as

Folate and iron metabolism in patients with tumors and inflammations

  • Peter Reizenstein
Nutritional Disturbances in Cancer Patients
  • 17 Downloads

Abstract

Reduced serum concentrations of nutrients like iron, zinc and folates and of albumin and cholesterol are found, as well as emaciation, both in malnutrition and in cancer. In patients with leukemia, a depletion of intracellular potassium and hypo-potassemia are found in addition. The use of hyperalimentation in cancer was originally based on the concept that too little food is the cause of these disturbances in the nutrition state. However, there is also a disturbed metabolism of nutrients in patients with tumors and inflammatory disease. In the case of folic acid, the disturbed metabolism could not be normalized by hyperalimentation. The more advanced the disease, the more pronounced is the disturbed nturient metabolism, and this disturbance is related to the macrophage activity. It is not self-evident, therefore, that hyperalimentation can normalize the nutritional state in cancer. Emaciation in cancer patients is not caused exclusively by malnutrition.

Key words

Cancer Nutrition Iron Folate Potassium 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Heber D, Byerly L O, Chlebowski T: Metabolic abnormalities in the cancer patient.Cancer 55, 225 (1985).PubMedCrossRefGoogle Scholar
  2. 2.
    Einhorn J, Reizenstein P: Metabolic studies on folic acid in malignancy.Cancer Res 26, 340 (1966).PubMedGoogle Scholar
  3. 3.
    Reizenstein P:The Biological Response to Disease: Hematologic Stress Syndrome. New York, Praeger (1983).Google Scholar
  4. 4.
    Reizenstein P, Bergström J, Carlmark B, Eliasson K, Ericsson F, Hultman E, Jogestrand T, Lantz B, Sundquist K: Total body potassium in lean body mass in heart and liver disease and leukemia, inAldosterone Antagonists in Clinical Medicine, p. 253. Amsterdam, Excerpta Medica (1978).Google Scholar
  5. 5.
    Supplement toCancer and Nutrition, vol. 55, no. 1 (1985).Google Scholar
  6. 6.
    Molin L, Reizenstein P: Hematological changes in psoriasis.Acta Derm Venereol (Stockholm) 54, 465 (1974).Google Scholar
  7. 7.
    Einhorn N, Reizenstein P: Prognostic significance of haematologic changes six years after irradiation of cervical carcinoma.Acta Radiol 13, 281 (1974).Google Scholar
  8. 8.
    Shizgal H: Body composition of patients with malnutrition and cancer. Summary of methods of assessment.Cancer 55, 250 (1985).PubMedCrossRefGoogle Scholar
  9. 9.
    Heymsfield S, McManus C: Tissue components of weight loss in cancer patients: a new method of study and preliminary observations.Cancer 55, 238 (1985).PubMedCrossRefGoogle Scholar
  10. 10.
    Chleboski R: Critical evaluation of the role of nutritional support with chemotherapy.Cancer 55, 268 (1985).CrossRefGoogle Scholar
  11. 11.
    Elman A, Einhorn J, Olhagen B, Reizenstein P: Metabolic studies of folic acid in non-malignant diseases.Acta Med Scand 187, 347 (1970).PubMedGoogle Scholar
  12. 12.
    Wiklund-Hammarström B, Gheorghescu B, Liljedahl S O, Nylind B. Reizenstein P: Reticuloendothelial function and some metabolic changes related to trauma, in DiLuzio N R (ed):The Reticuloendothelial System and Immune Phenomena, p. 333. New York, Plenum Press (1971).Google Scholar
  13. 13.
    Reizenstein P: Leukemia and nutrition (in Swedish).Nordish Medicin 83, 74 (1970).Google Scholar

Copyright information

© Humana Press Inc. 1985

Authors and Affiliations

  • Peter Reizenstein
    • 1
  1. 1.Division of HematologyKarolinska Hospital and InstituteStockholmSweden

Personalised recommendations